https://www.ophthalmologytimes.com/view/angiogenesis-2023-ocular-therapeutix-announces-data-from-phase-1-clinical-trial-evaluating-otx-tki-for-treatment-of-wet-amd
0
0
2/12/23 at 1:12pm
Organization
Ophthalmologytimes.com
Author
David Hutton
The company noted that all OTX-TKI treated subjects who were rescue-free at the Month 7 interim analysis remained rescue-free, extending the 73% rescue-free rate up to Month 10.
Create an account
or login to join the discussion